Univ. of Alabama/Division of Clinical Immunology and Rheumatology — Birmingham, Alabama

Univ. of Alabama/Division of Clinical Immunology and Rheumatology is a clinical research site located in Birmingham, Alabama, United States 35294.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Univ. of Alabama/Division of Clinical Immunology and Rheumatology has participated in 1 clinical trials.

Therapeutic areas: Osteoporosis.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Birmingham

Browse all research sites in Alabama · View every site in Birmingham

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Univ. of Alabama/Division of Clinical Immunology and Rheumatology?

Univ. of Alabama/Division of Clinical Immunology and Rheumatology has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Univ. of Alabama/Division of Clinical Immunology and Rheumatology conducted?

Univ. of Alabama/Division of Clinical Immunology and Rheumatology has 1 clinical trials on record. Their work covers Osteoporosis.

Is Univ. of Alabama/Division of Clinical Immunology and Rheumatology accredited by Crixeo Clinical Trials?

Univ. of Alabama/Division of Clinical Immunology and Rheumatology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Univ. of Alabama/Division of Clinical Immunology and Rheumatology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.